SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-125555
Filing Date
2022-04-28
Accepted
2022-04-28 08:30:58
Documents
5
Period of Report
2022-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A d268305ddef14a.htm DEF 14A 391717
2 GRAPHIC g268305dsp050.jpg GRAPHIC 107858
3 GRAPHIC g268305dsp051.jpg GRAPHIC 138754
4 GRAPHIC g268305g01a04.jpg GRAPHIC 59301
5 GRAPHIC g268305g02a02.jpg GRAPHIC 63712
  Complete submission text file 0001193125-22-125555.txt   902413
Mailing Address 215 FIRST STREET SUITE 430 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 430 CAMBRIDGE MA 02142 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39979 | Film No.: 22862429
SIC: 2836 Biological Products, (No Diagnostic Substances)